Respiratory Treatments Hit Hardest By HTA Terminations In England

 
• By Leela Barham
  
Availability of respiratory disease treatments are affected by failure to submit evidence to NICE health technology appraisals in England. (Shutterstock)

More from Health Technology Assessment

More from United Kingdom